MEVAC LSD

MEVAC LSD is a veterinary vaccine developed by Middle East for Vaccines (MEVAC) for the active immunization of ruminants, primarily cattle, against Lumpy Skin Disease (LSD). The vaccine is a live-attenuated preparation, typically derived from the Neethling strain of the Lumpy Skin Disease Virus (LSDV), which is a member of the Capripoxvirus genus. It is designed to stimulate a robust and long-lasting immune response, including both humoral and cell-mediated immunity, to prevent the clinical manifestations of LSD such as fever, skin nodules, and internal lesions. The vaccine is used as a critical tool in livestock management to control the spread of the virus in endemic regions and during outbreak scenarios.

Brand names

MEVAC LSD

Other names

Lumpy Skin Disease Vaccine (MEVAC)Lumpy Skin Disease Vaccine-Middle East for Vaccines-veterinary vaccine-Lumpy Skin Disease (Ruminants)